USPTO serial 79097546
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of bacterial diseases; pharmaceutical preparations for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotic and antifungal preparations; vaccines; diagnostic preparations for medical use | SECTION 70 - CANCELLED | — |
| 042 | Scientific and technological services for medical purposes and research and design services relating thereto, namely services of pharmaceutical research and development; consulting services in the field of pharmaceutical research and development | SECTION 70 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 5, 2021 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 4, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 26, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 19, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 14, 2013 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 18, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 18, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 9, 2012 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 21, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 21, 2012 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 18, 2012 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 18, 2012 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 13, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 25, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 22, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 22, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 22, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 21, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2011 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 16, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |